Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Isolation and characterization of 14 polymorphic microsatellite markers for the blue and red shrimp, Aristeus antennatus (Crustacea, Decapoda).

Molecular ecology resources

Cannas R, Buccoli S, Sacco F, Marcias S, Salvadori S, Cau A, Deiana A.
PMID: 21586064
Mol Ecol Resour. 2008 Nov;8(6):1420-2. doi: 10.1111/j.1755-0998.2008.02183.x. Epub 2008 Jul 18.

Eighteen microsatellite loci were isolated and characterized from the blue and red shrimp, Aristeus antennatus Risso 1816, a commercially exploited marine crustacean widely distributed throughout the Mediterranean Sea and in the eastern Atlantic. Polymorphism was assessed in a population...

Cite
Cannas R, Buccoli S, Sacco F, et al. Isolation and characterization of 14 polymorphic microsatellite markers for the blue and red shrimp, Aristeus antennatus (Crustacea, Decapoda). Mol Ecol Resour. 2008;8(6):1420-2doi: 10.1111/j.1755-0998.2008.02183.x.
Cannas, R., Buccoli, S., Sacco, F., Marcias, S., Salvadori, S., Cau, A., & Deiana, A. (2008). Isolation and characterization of 14 polymorphic microsatellite markers for the blue and red shrimp, Aristeus antennatus (Crustacea, Decapoda). Molecular ecology resources, 8(6), 1420-2. https://doi.org/10.1111/j.1755-0998.2008.02183.x
Cannas, Rita, et al. "Isolation and characterization of 14 polymorphic microsatellite markers for the blue and red shrimp, Aristeus antennatus (Crustacea, Decapoda)." Molecular ecology resources vol. 8,6 (2008): 1420-2. doi: https://doi.org/10.1111/j.1755-0998.2008.02183.x
Cannas R, Buccoli S, Sacco F, Marcias S, Salvadori S, Cau A, Deiana A. Isolation and characterization of 14 polymorphic microsatellite markers for the blue and red shrimp, Aristeus antennatus (Crustacea, Decapoda). Mol Ecol Resour. 2008 Nov;8(6):1420-2. doi: 10.1111/j.1755-0998.2008.02183.x. Epub 2008 Jul 18. PMID: 21586064.
Copy Download .nbib Format: NLM
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.

Journal of medicinal chemistry

Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS.
PMID: 34748351
J Med Chem. 2021 Dec 23;64(24):17753-17776. doi: 10.1021/acs.jmedchem.1c00944. Epub 2021 Nov 08.

Accumulation of very long chain fatty acids (VLCFAs) due to defects in ATP binding cassette protein D1 (ABCD1) is thought to underlie the pathologies observed in adrenoleukodystrophy (ALD). Pursuing a substrate reduction approach based on the inhibition of elongation...

Cite
Come JH, Senter TJ, Clark MP, et al. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021;64(24):17753-17776doi: 10.1021/acs.jmedchem.1c00944.
Come, J. H., Senter, T. J., Clark, M. P., Court, J. J., Gale-Day, Z., Gu, W., Krueger, E., Liang, J., Morris, M., Nanthakumar, S., O'Dowd, H., Maltais, F., Iyer, G., Andreassi, J., Boucher, C., Considine, T., Moody, C. S., Taylor, W., Mohanty, A. K., Huang, Y., Zuccola, H., Coll, J., Bonanno, K. C., Gagnon, K. J., Gan, L., Lu, F., Gao, H., Chakilam, A., Engtrakul, J., Song, B., Crawford, D., Doyle, E., Kramer, T., Vought, B., Phillips, J., Kemper, R., Sanders, M., Swett, R., Furey, B., Winquist, R., Bunnage, M. E., Jackson, K. L., Charifson, P. S., & Magavi, S. S. (2021). Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. Journal of medicinal chemistry, 64(24), 17753-17776. https://doi.org/10.1021/acs.jmedchem.1c00944
Come, Jon H, et al. "Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1." Journal of medicinal chemistry vol. 64,24 (2021): 17753-17776. doi: https://doi.org/10.1021/acs.jmedchem.1c00944
Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021 Dec 23;64(24):17753-17776. doi: 10.1021/acs.jmedchem.1c00944. Epub 2021 Nov 08. PMID: 34748351.
Copy Download .nbib Format: NLM
Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory study.

General psychiatry

Petralia A, Bisso E, Concas I, Maglitto A, Bucolo N, Alaimo S, Di Cataldo A, Signorelli MS, Pulvirenti A, Aguglia E.
PMID: 34308150
Gen Psychiatr. 2021 Jul 02;34(4):e100307. doi: 10.1136/gpsych-2020-100307. eCollection 2021.

BACKGROUND: The incidence of paediatric cancers has increased in recent years; however, with advances in the treatment of paediatric cancer, almost 80% of children and adolescents who receive a diagnosis of cancer become long-term survivors. Given the high stress...

Cite
Petralia A, Bisso E, Concas I, et al. Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory study. Gen Psychiatr. 2021;34(4):e100307doi: 10.1136/gpsych-2020-100307.
Petralia, A., Bisso, E., Concas, I., Maglitto, A., Bucolo, N., Alaimo, S., Di Cataldo, A., Signorelli, M. S., Pulvirenti, A., & Aguglia, E. (2021). Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory study. General psychiatry, 34(4), e100307. https://doi.org/10.1136/gpsych-2020-100307
Petralia, Antonino, et al. "Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory study." General psychiatry vol. 34,4 (2021): e100307. doi: https://doi.org/10.1136/gpsych-2020-100307
Petralia A, Bisso E, Concas I, Maglitto A, Bucolo N, Alaimo S, Di Cataldo A, Signorelli MS, Pulvirenti A, Aguglia E. Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory study. Gen Psychiatr. 2021 Jul 02;34(4):e100307. doi: 10.1136/gpsych-2020-100307. eCollection 2021. PMID: 34308150; PMCID: PMC8256730.
Copy Download .nbib Format: NLM
A clinical translation of the research article titled, "alcohol and violence-related injuries among emergency room patients in an international perspective".

Journal of the American Psychiatric Nurses Association

Buccola NG, Rosedale M, Bryan T.
PMID: 21659275
J Am Psychiatr Nurses Assoc. 2010 Jul;16(4):236-8. doi: 10.1177/1078390310375847.

No abstract available.

Cite
Buccola NG, Rosedale M, Bryan T. A clinical translation of the research article titled, "alcohol and violence-related injuries among emergency room patients in an international perspective". J Am Psychiatr Nurses Assoc. 2010;16(4):236-8doi: 10.1177/1078390310375847.
Buccola, N. G., Rosedale, M., & Bryan, T. (2010). A clinical translation of the research article titled, "alcohol and violence-related injuries among emergency room patients in an international perspective". Journal of the American Psychiatric Nurses Association, 16(4), 236-8. https://doi.org/10.1177/1078390310375847
Buccola, Nancy G, et al. "A clinical translation of the research article titled, "alcohol and violence-related injuries among emergency room patients in an international perspective"." Journal of the American Psychiatric Nurses Association vol. 16,4 (2010): 236-8. doi: https://doi.org/10.1177/1078390310375847
Buccola NG, Rosedale M, Bryan T. A clinical translation of the research article titled, "alcohol and violence-related injuries among emergency room patients in an international perspective". J Am Psychiatr Nurses Assoc. 2010 Jul;16(4):236-8. doi: 10.1177/1078390310375847. PMID: 21659275.
Copy Download .nbib Format: NLM
Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions.

ACS medicinal chemistry letters

Wang T, Bemis G, Hanzelka B, Zuccola H, Wynn M, Moody CS, Green J, Locher C, Liu A, Gao H, Xu Y, Wang S, Wang J, Bennani YL, Thomson JA, Müh U.
PMID: 29259738
ACS Med Chem Lett. 2017 Nov 28;8(12):1224-1229. doi: 10.1021/acsmedchemlett.7b00239. eCollection 2017 Dec 14.

Drug resistant tuberculosis (TB) infections are on the rise and antibiotics that inhibit

Cite
Wang T, Bemis G, Hanzelka B, et al. Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. ACS Med Chem Lett. 2017;8(12):1224-1229doi: 10.1021/acsmedchemlett.7b00239.
Wang, T., Bemis, G., Hanzelka, B., Zuccola, H., Wynn, M., Moody, C. S., Green, J., Locher, C., Liu, A., Gao, H., Xu, Y., Wang, S., Wang, J., Bennani, Y. L., Thomson, J. A., & Müh, U. (2017). Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. ACS medicinal chemistry letters, 8(12), 1224-1229. https://doi.org/10.1021/acsmedchemlett.7b00239
Wang, Tiansheng, et al. "Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions." ACS medicinal chemistry letters vol. 8,12 (2017): 1224-1229. doi: https://doi.org/10.1021/acsmedchemlett.7b00239
Wang T, Bemis G, Hanzelka B, Zuccola H, Wynn M, Moody CS, Green J, Locher C, Liu A, Gao H, Xu Y, Wang S, Wang J, Bennani YL, Thomson JA, Müh U. Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. ACS Med Chem Lett. 2017 Nov 28;8(12):1224-1229. doi: 10.1021/acsmedchemlett.7b00239. eCollection 2017 Dec 14. PMID: 29259738; PMCID: PMC5733270.
Copy Download .nbib Format: NLM
Oesophageal Adenocarcinoma: A Patient and Physician's Perspective.

Oncology and therapy

Maule D, Boccola M, Lord RV.
PMID: 28680958
Oncol Ther. 2017;5(1):79-84. doi: 10.1007/s40487-017-0044-4. Epub 2017 Apr 19.

This article is co-authored by a patient with oesophageal adenocarcinoma and his physician, who performed oesophagectomy. The patient relates his pre-operative preparation and post-operative experience. The physician comments on the alarming increase in the incidence of this cancer, risk...

Cite
Maule D, Boccola M, Lord RV. Oesophageal Adenocarcinoma: A Patient and Physician's Perspective. Oncol Ther. 2017;5(1):79-84doi: 10.1007/s40487-017-0044-4.
Maule, D., Boccola, M., & Lord, R. V. (2017). Oesophageal Adenocarcinoma: A Patient and Physician's Perspective. Oncology and therapy, 5(1), 79-84. https://doi.org/10.1007/s40487-017-0044-4
Maule, Derek, et al. "Oesophageal Adenocarcinoma: A Patient and Physician's Perspective." Oncology and therapy vol. 5,1 (2017): 79-84. doi: https://doi.org/10.1007/s40487-017-0044-4
Maule D, Boccola M, Lord RV. Oesophageal Adenocarcinoma: A Patient and Physician's Perspective. Oncol Ther. 2017;5(1):79-84. doi: 10.1007/s40487-017-0044-4. Epub 2017 Apr 19. PMID: 28680958; PMCID: PMC5488084.
Copy Download .nbib Format: NLM
Competition and Symmetry in an Artificial Word Learning Task.

Frontiers in psychology

Buccola B, Dautriche I, Chemla E.
PMID: 30555366
Front Psychol. 2018 Nov 13;9:2176. doi: 10.3389/fpsyg.2018.02176. eCollection 2018.

Natural language involves competition. The sentences we choose to utter activate alternative sentences (those we chose not to utter), which hearers typically infer to be false. Hence, as a first approximation, the more alternatives a sentence activates, the more...

Cite
Buccola B, Dautriche I, Chemla E. Competition and Symmetry in an Artificial Word Learning Task. Front Psychol. 2018;9:2176doi: 10.3389/fpsyg.2018.02176.
Buccola, B., Dautriche, I., & Chemla, E. (2018). Competition and Symmetry in an Artificial Word Learning Task. Frontiers in psychology, 92176. https://doi.org/10.3389/fpsyg.2018.02176
Buccola, Brian, et al. "Competition and Symmetry in an Artificial Word Learning Task." Frontiers in psychology vol. 9 (2018): 2176. doi: https://doi.org/10.3389/fpsyg.2018.02176
Buccola B, Dautriche I, Chemla E. Competition and Symmetry in an Artificial Word Learning Task. Front Psychol. 2018 Nov 13;9:2176. doi: 10.3389/fpsyg.2018.02176. eCollection 2018. PMID: 30555366; PMCID: PMC6282061.
Copy Download .nbib Format: NLM
Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling.

Frontiers in oncology

Chierici M, Bussola N, Marcolini A, Francescatto M, Zandonà A, Trastulla L, Agostinelli C, Jurman G, Furlanello C.
PMID: 32714870
Front Oncol. 2020 Jun 30;10:1065. doi: 10.3389/fonc.2020.01065. eCollection 2020.

Recent technological advances and international efforts, such as The Cancer Genome Atlas (TCGA), have made available several pan-cancer datasets encompassing multiple omics layers with detailed clinical information in large collection of samples. The need has thus arisen for the...

Cite
Chierici M, Bussola N, Marcolini A, et al. Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling. Front Oncol. 2020;10:1065doi: 10.3389/fonc.2020.01065.
Chierici, M., Bussola, N., Marcolini, A., Francescatto, M., Zandonà, A., Trastulla, L., Agostinelli, C., Jurman, G., & Furlanello, C. (2020). Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling. Frontiers in oncology, 101065. https://doi.org/10.3389/fonc.2020.01065
Chierici, Marco, et al. "Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling." Frontiers in oncology vol. 10 (2020): 1065. doi: https://doi.org/10.3389/fonc.2020.01065
Chierici M, Bussola N, Marcolini A, Francescatto M, Zandonà A, Trastulla L, Agostinelli C, Jurman G, Furlanello C. Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling. Front Oncol. 2020 Jun 30;10:1065. doi: 10.3389/fonc.2020.01065. eCollection 2020. PMID: 32714870; PMCID: PMC7340129.
Copy Download .nbib Format: NLM
The cost of problem-based vs. traditional medical education. I. Faculty time during the freshman year.

Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education

Mennin SP, Burrola N.
PMID: 6571661
Res Med Educ. 1984;23:33-8.

No abstract available.

Cite
Mennin SP, Burrola N. The cost of problem-based vs. traditional medical education. I. Faculty time during the freshman year. Res Med Educ. 1984;23:33-8
Mennin, S. P., & Burrola, N. (1984). The cost of problem-based vs. traditional medical education. I. Faculty time during the freshman year. Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education, 2333-8.
Mennin, S P, and Burrola, N. "The cost of problem-based vs. traditional medical education. I. Faculty time during the freshman year." Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education vol. 23 (1984): 33-8.
Mennin SP, Burrola N. The cost of problem-based vs. traditional medical education. I. Faculty time during the freshman year. Res Med Educ. 1984;23:33-8. PMID: 6571661.
Copy Download .nbib Format: NLM
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.

Journal of medicinal chemistry

Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS.
PMID: 34748351
J Med Chem. 2021 Dec 23;64(24):17753-17776. doi: 10.1021/acs.jmedchem.1c00944. Epub 2021 Nov 08.

Accumulation of very long chain fatty acids (VLCFAs) due to defects in ATP binding cassette protein D1 (ABCD1) is thought to underlie the pathologies observed in adrenoleukodystrophy (ALD). Pursuing a substrate reduction approach based on the inhibition of elongation...

Cite
Come JH, Senter TJ, Clark MP, et al. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021;64(24):17753-17776doi: 10.1021/acs.jmedchem.1c00944.
Come, J. H., Senter, T. J., Clark, M. P., Court, J. J., Gale-Day, Z., Gu, W., Krueger, E., Liang, J., Morris, M., Nanthakumar, S., O'Dowd, H., Maltais, F., Iyer, G., Andreassi, J., Boucher, C., Considine, T., Moody, C. S., Taylor, W., Mohanty, A. K., Huang, Y., Zuccola, H., Coll, J., Bonanno, K. C., Gagnon, K. J., Gan, L., Lu, F., Gao, H., Chakilam, A., Engtrakul, J., Song, B., Crawford, D., Doyle, E., Kramer, T., Vought, B., Phillips, J., Kemper, R., Sanders, M., Swett, R., Furey, B., Winquist, R., Bunnage, M. E., Jackson, K. L., Charifson, P. S., & Magavi, S. S. (2021). Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. Journal of medicinal chemistry, 64(24), 17753-17776. https://doi.org/10.1021/acs.jmedchem.1c00944
Come, Jon H, et al. "Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1." Journal of medicinal chemistry vol. 64,24 (2021): 17753-17776. doi: https://doi.org/10.1021/acs.jmedchem.1c00944
Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021 Dec 23;64(24):17753-17776. doi: 10.1021/acs.jmedchem.1c00944. Epub 2021 Nov 08. PMID: 34748351.
Copy Download .nbib Format: NLM
Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Moretta P, Lanzillo A, Lo Sapio MD, Spaccavento S, Cellamare F, Nisoli F, Ianni A, Pain D, Feroldi S, Forlani CA, Boccola S, Madonia F, Volanti P, Pierobon A, Scola I, Manera M, Bertolotti G, Trojano L.
PMID: 33856583
Neurol Sci. 2021 Jun;42(6):2601. doi: 10.1007/s10072-021-05256-5.

No abstract available.

Cite
Moretta P, Lanzillo A, Lo Sapio MD, et al. Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study. Neurol Sci. 2021;42(6):2601doi: 10.1007/s10072-021-05256-5.
Moretta, P., Lanzillo, A., Lo Sapio, M. D., Spaccavento, S., Cellamare, F., Nisoli, F., Ianni, A., Pain, D., Feroldi, S., Forlani, C. A., Boccola, S., Madonia, F., Volanti, P., Pierobon, A., Scola, I., Manera, M., Bertolotti, G., & Trojano, L. (2021). Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(6), 2601. https://doi.org/10.1007/s10072-021-05256-5
Moretta, Pasquale, et al. "Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. 42,6 (2021): 2601. doi: https://doi.org/10.1007/s10072-021-05256-5
Moretta P, Lanzillo A, Lo Sapio MD, Spaccavento S, Cellamare F, Nisoli F, Ianni A, Pain D, Feroldi S, Forlani CA, Boccola S, Madonia F, Volanti P, Pierobon A, Scola I, Manera M, Bertolotti G, Trojano L. Correction to: The Italian validation of the communicative effectiveness index questionnaire: a multicentric study. Neurol Sci. 2021 Jun;42(6):2601. doi: 10.1007/s10072-021-05256-5. PMID: 33856583.
Copy Download .nbib Format: NLM
Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression.

Frontiers in oncology

Quagliariello V, Berretta M, Buccolo S, Iovine M, Paccone A, Cavalcanti E, Taibi R, Montopoli M, Botti G, Maurea N.
PMID: 34178667
Front Oncol. 2021 Jun 11;11:680758. doi: 10.3389/fonc.2021.680758. eCollection 2021.

Renal cell carcinoma (RCC) represents the main renal tumors and are highly metastatic. Sunitinib, a recently-approved, multi-targeted Tyrosine Kinases Inhibitor (TKi), prolongs survival in patients with metastatic renal cell carcinoma and gastrointestinal stromal tumors, however a dose related cardiotoxicity...

Cite
Quagliariello V, Berretta M, Buccolo S, et al. Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression. Front Oncol. 2021;11:680758doi: 10.3389/fonc.2021.680758.
Quagliariello, V., Berretta, M., Buccolo, S., Iovine, M., Paccone, A., Cavalcanti, E., Taibi, R., Montopoli, M., Botti, G., & Maurea, N. (2021). Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression. Frontiers in oncology, 11680758. https://doi.org/10.3389/fonc.2021.680758
Quagliariello, Vincenzo, et al. "Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression." Frontiers in oncology vol. 11 (2021): 680758. doi: https://doi.org/10.3389/fonc.2021.680758
Quagliariello V, Berretta M, Buccolo S, Iovine M, Paccone A, Cavalcanti E, Taibi R, Montopoli M, Botti G, Maurea N. Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression. Front Oncol. 2021 Jun 11;11:680758. doi: 10.3389/fonc.2021.680758. eCollection 2021. PMID: 34178667; PMCID: PMC8226180.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries